ORG Partners’s Biohaven BHVN Stock Holding History

ORG Partners’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-40	Closed	-$600	–	1713
2025 Q3	$600	Sell	40 -3	-7%	-$44	﹤0.01%	1455
2025 Q2	$600	Hold	43	–	–	﹤0.01%	1390
2025 Q1	$971	Buy	+43	New	+$1.52K	﹤0.01%	1180

Other funds holding BHVN

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $242M AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ORG Partners's BHVN Position: Q4 2025 in Review

ORG Partners sold out of Biohaven (BHVN) in Q4 2025, closing a stake of 40 shares — an estimated $600 sold.

ORG Partners first reported a position in BHVN in Q1 2025 and held it in 3 quarters. The position peaked at $971 in Q1 2025. 273 funds tracked by Wall St. Rank hold BHVN as of Q4 2025.

ORG Partners reported no remaining Biohaven position as of Q4 2025 after selling out during the quarter.
ORG Partners sold 40 Biohaven shares in Q4 2025, an estimated $600.
ORG Partners first reported a position in Biohaven in Q1 2025 and held it in 3 quarters.
ORG Partners's Biohaven position peaked at $971 in Q1 2025.
273 funds tracked by Wall St. Rank held Biohaven as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.